Shaping the Future of Cancer Care
Bayer is advancing targeted therapies, collaboration and patient support to improve outcomes for people living with cancer.
Gastrointestinal Stromal Tumor (GIST)
Gastrointestinal Stromal Tumor (GIST) are a type of cancer that originates in the connective tissues of the digestive system, particularly in the stomach or intestines. These tumors are unique because they often have specific genetic mutations that can be targeted with specialized therapies
Liver Cancer
Liver Cancer is one of the most common cancers worldwide, affecting an essential organ responsible for various functions, including filtering toxins from the blood and aiding in digestion. Dedicated research and treatment strategies aim at enhancing the health and well-being of individuals diagnosed with liver cancer.
Prostate Cancer
Prostate Cancer is one of the most common cancers among men, particularly in older age groups. Research and treatment strategies aim at improving personalized care for prostate cancer by using treatments that are specifically designed to match the unique characteristics of the disease in each patient.
Kidney Cancer
Kidney Cancer typically affects adults, especially those over the age of 50. Recent advancements in treatment options, including targeted therapies and immunotherapy, are helping to improve disease control and provide better outcomes for patients.
Thyroid Cancer
Thyroid Cancer is a type of cancer that begins in the thyroid gland, which is a butterfly-shaped gland located at the base of the neck. is one of the fastest-growing cancer types, particularly among women, who are three times more likely to be diagnosed than men. It often occurs in younger individuals, and while it can be serious, most cases have a good prognosis and can be treated effectively.
TRK Fusion Cancer
TRK Fusion Cancer are genetic changes that occur when parts of different genes come together, creating a new gene that can promote cancer growth. These fusions can be found in several cancer types, including sarcomas, lung cancer, and certain types of breast cancer. The development of precision therapies aimed at these specific genetic alterations allows for more personalized treatment plans, which can lead to better responses and fewer side effects compared to traditional therapies.
Breast Cancer
Ongoing research is crucial for discovering new treatment options, improving early detection methods, and providing better support for patients and their families. By focusing on these areas, healthcare providers and researchers aim to enhance the overall care and quality of life for those affected by breast cancer.
Colorectal Cancer
Colorectal Cancer is one of the most common cancers worldwide with the majority of cases diagnosed in individuals over the age of 50. By focusing on innovative detection methods, such as advanced screening techniques, and developing more effective treatment options, researchers and healthcare providers aim to improve outcomes and survival rates for those diagnosed with colorectal cancer.
Non-Small Cell Lung Cancer
Based on 2022 data, it is estimated that among the ~ 2 million people diagnosed with non-small cell lung cancer (NSCLC) globally, about 60,000 have an activating HER2 mutation. Activating HER2 mutations NSCLC were identified in 2004. But, despite ongoing research, there’s still much to learn two decades later.